X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DR. REDDYS LAB DR. DATSONS LABS/
DR. REDDYS LAB
 
P/E (TTM) x -10.9 27.3 - View Chart
P/BV x 0.2 2.8 5.8% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 DR. DATSONS LABS   DR. REDDYS LAB
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DR. REDDYS LAB
Mar-16
DR. DATSONS LABS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1264,383 2.9%   
Low Rs312,750 1.1%   
Sales per share (Unadj.) Rs133.0920.1 14.5%  
Earnings per share (Unadj.) Rs0.2126.1 0.1%  
Cash flow per share (Unadj.) Rs6.6183.0 3.6%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.8685.8 18.8%  
Shares outstanding (eoy) m31.66170.61 18.6%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.63.9 15.2%   
Avg P/E ratio x516.128.3 1,824.9%  
P/CF ratio (eoy) x11.819.5 60.8%  
Price / Book Value ratio x0.65.2 11.7%  
Dividend payout %015.9 0.0%   
Avg Mkt Cap Rs m2,477608,481 0.4%   
No. of employees `000NA21.7 0.0%   
Total wages/salary Rs m5631,874 0.2%   
Avg. sales/employee Rs ThNM7,244.4-  
Avg. wages/employee Rs ThNM1,470.9-  
Avg. net profit/employee Rs ThNM992.8-  
INCOME DATA
Net Sales Rs m4,211156,978 2.7%  
Other income Rs m792,693 2.9%   
Total revenues Rs m4,289159,671 2.7%   
Gross profit Rs m56934,587 1.6%  
Depreciation Rs m2049,705 2.1%   
Interest Rs m430824 52.2%   
Profit before tax Rs m1326,751 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m65,237 0.1%   
Profit after tax Rs m521,514 0.0%  
Gross profit margin %13.522.0 61.3%  
Effective tax rate %48.019.6 245.3%   
Net profit margin %0.113.7 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,852118,201 5.8%   
Current liabilities Rs m6,71168,368 9.8%   
Net working cap to sales %3.331.7 10.5%  
Current ratio x1.01.7 59.1%  
Inventory Days Days16160 268.1%  
Debtors Days Days31897 328.7%  
Net fixed assets Rs m3,67372,265 5.1%   
Share capital Rs m317853 37.1%   
"Free" reserves Rs m3,761111,548 3.4%   
Net worth Rs m4,078117,009 3.5%   
Long term debt Rs m1,67110,690 15.6%   
Total assets Rs m12,633200,104 6.3%  
Interest coverage x1.033.5 3.1%   
Debt to equity ratio x0.40.1 448.5%  
Sales to assets ratio x0.30.8 42.5%   
Return on assets %3.411.2 30.8%  
Return on equity %0.118.4 0.6%  
Return on capital %7.721.6 35.5%  
Exports to sales %22.946.3 49.5%   
Imports to sales %14.39.0 159.7%   
Exports (fob) Rs m96472,618 1.3%   
Imports (cif) Rs m60214,050 4.3%   
Fx inflow Rs m96475,405 1.3%   
Fx outflow Rs m60727,115 2.2%   
Net fx Rs m35748,290 0.7%   
CASH FLOW
From Operations Rs m1,34540,476 3.3%  
From Investments Rs m-2,256-19,421 11.6%  
From Financial Activity Rs m-1,200-17,009 7.1%  
Net Cashflow Rs m-2,1114,046 -52.2%  

Share Holding

Indian Promoters % 4.5 25.5 17.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.4 -  
FIIs % 1.4 35.3 3.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 94.1 15.3 615.0%  
Shareholders   20,807 75,885 27.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NATCO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare DR. DATSONS LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS